The relations between quality of life, morbidity of chronic non-infectious diseases and use of medications in stroke patients
Анотація
Objective. To determine relations between quality of life, morbidity of chronic non-infectious diseases and use of pharmaceuticals by stroke patients. Material and methods. The case group consisted of 508 Kaunas citizens, aged 25-84 years, who survived the stroke. The control group consisted of randomly chosen 508 sex- and age-matched Kaunas citizens without stroke. SF-12 questionnaire on the quality of life was used. Quality of life was analysed in physical and mental health domains taking into consideration morbidity of chronic non-infectious diseases and use of pharmaceuticals. The percentage of those who had more than one chronic non-infectious disease was 38.6 in the case group and 17.2 in the control group (p<0.001). With respect to the use of antihypertensive (66.5% in the case group and 67.3% in the control group), antithrombotic (21.5% and 24.6%) and antidepressant (100% and 100%) medication, case and control groups were similar. Results and conclusion. Compared to people without arterial hypertension, scores in physical health domain were lower in people with arterial hypertension (p=0.018) and the control group (p=0,0005). In the main group, people without atrial fibrillation scored lower (p=0.0005) in physical health domain compared to those with atrial fibrillation. Scores in mental health domain were lower in the control group (p=0.048). Compared to people with diabetes mellitus (DM), those with DM scored lower in the case group (p=0.0005). The use of antihypertensive or antithrombotic medication before stroke did not predict quality of life in patients with chronic non-infectious diseases. Meanwhile, in the control group the use of antithrombotic medication improved (p<0.05) the quality of life in physical health domain.
Класифікація
Ідентифікатори
Рецензії (0)
Написати рецензіюРецензій ще немає. Будьте першим!
Схожі роботи
The European Cancer Patient’s Bill of Rights, update and implementation 2016
Схоже за: Health Systems, Economic Evaluations, Quality of Life
Double-Crossed: Why Crossover in Clinical Trials May Be Distorting Medical Science
Схоже за: Health Systems, Economic Evaluations, Quality of Life
Modern approaches to typologization and modeling in the health technology assessment
Схоже за: Health Systems, Economic Evaluations, Quality of Life
EXPERT EVALUATION OF THE CLINICAL TRIAL MANAGEMENT MODEL WITH AN OPTIMIZED REGULATORY SYSTEM AT THE LEVEL OF A CONTRACT RESEARCH ORGANIZATION
Схоже за: Health Systems, Economic Evaluations, Quality of Life
Continuing education in geriatrics: An imperative for elderly care
Схоже за: Health Systems, Economic Evaluations, Quality of Life
Analysis of the state of training of specialists in the health technology assessment in the world
Схоже за: Health Systems, Economic Evaluations, Quality of Life